N-acetylcysteine for belly infection in cirrhosis
Treatments studied
Part of Digestive system, Infections clinical trials.
This study tests whether adding N-acetylcysteine (an antioxidant supplement) to standard treatment helps fight an infection in the belly fluid of people with liver cirrhosis. It aims to improve recovery and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have cirrhosis of the liver
- You have a new diagnosis of spontaneous bacterial peritonitis (infection in belly fluid) confirmed by a fluid sample
- You have not had recent abdominal surgery or need emergency surgery
- You are not allergic to N-acetylcysteine
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether an antiparasitic medicine called nitazoxanide can help treat a type of infection in the belly fluid that happens in people with liver cirrhosis. If you have cirrhosis and this infection, joining might give you access to a new treatment option.
This trial tests if N-acetylcysteine, a medicine that helps the liver and fights inflammation, can improve outcomes for adults with a severe infection and liver stress.
This study tests whether adding N-acetylcysteine to standard treatment helps people with severe alcoholic hepatitis. It may improve liver outcomes, especially for those with a high Maddrey score.
This study tests whether a medicine called NAC (an antioxidant that helps protect the liver) can be safely given to infants with biliary atresia by mouth. It aims to see if babies can tolerate it, which might eventually help their liver health.
This trial tests whether the drug N-acetylcysteine (NAC) can help people with sudden liver failure that is not caused by acetaminophen (like Tylenol). If you qualify, you may receive NAC, which might help your liver recover.
This study tests whether adding a probiotic to standard antibiotics helps treat an infection in the abdominal fluid of people with cirrhosis (called spontaneous bacterial peritonitis) and prevents it from coming back.
Hear when a new SBP - Spontaneous Bacterial Peritonitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.